Fig. 7From: Targeting the eCIRP/TREM-1 interaction with a small molecule inhibitor improves cardiac dysfunction in neonatal sepsisrmCIRP increases oxidative stress in cardiomyocytes and causes mitochondrial dysfunction. Primary murine neonatal cardiomyocytes were isolated. Cardiomyocyte and mitochondrial oxidative stress were quantified using a DCF (N = 8/group) and b MitoSOX Red fluorescence (N = 8/group). Mitochondrial membrane potential and calcium levels was assessed using c Tetramethylrhodamine methyl ester (TMRM) (PBS = 27 and 13 per group for rest) and d Rohd2 AM (N = 5/group) fluorescence. After rmCIRP stimulation, there was a significant dose-dependent increase in cardiomyocyte and mitochondrial-specific reactive oxygen species; this was ameliorated by M3 (a, b). Stimulation of cardiomyocytes with rmCIRP resulted in a reduction in mitochondrial membrane potential while M3 treatment returned membrane potential to near baseline (c). rmCIRP caused mitochondrial calcium overload; this was inhibited by M3 (d). Data shown are the results of two to three independent experiments. Multiple groups were compared by one-way ANOVA and Tukey method (*p < 0.05 vs. PBS control; % p < 0.05 vs 2 µg/mL rmCIRP, #p < 0.05 vs 4 µg/mL rmCIRP)Back to article page